000			01993 a2200469 4500
005			20250515115155.0
264		0	_c20080529
008			200805s 0 0 eng d
022			_a1522-726X
024	7		_a10.1002/ccd.21518 _2doi
040			_aNLM _beng _cNLM
100	1		_aBrodie, Bruce R
245	0	0	_aWhat anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice? _h[electronic resource]
260			_bCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions _cMay 2008
300			_a816-21 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAngioplasty, Balloon, Coronary _xadverse effects
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aAspirin _xtherapeutic use
650	0	4	_aCardiovascular Diseases _xetiology
650	0	4	_aClopidogrel
650	0	4	_aFibrinolytic Agents _xadverse effects
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHeparin _xtherapeutic use
650	0	4	_aHirudins
650	0	4	_aHumans
650	0	4	_aMyocardial Infarction _xmortality
650	0	4	_aPatient Selection
650	0	4	_aPeptide Fragments _xtherapeutic use
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aResearch Design
650	0	4	_aStents
650	0	4	_aThrombin _xantagonists & inhibitors
650	0	4	_aThrombosis _xetiology
650	0	4	_aTiclopidine _xanalogs & derivatives
650	0	4	_aTreatment Outcome
773	0		_tCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions _gvol. 71 _gno. 6 _gp. 816-21
856	4	0	_uhttps://doi.org/10.1002/ccd.21518 _zAvailable from publisher's website
999			_c17910221 _d17910221